Position in CCCC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$727,964
+$539,799 QoQ
Shares Held
155,881
+117.9% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. CCCC ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $727,964 | 155,881 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $188,165 | 71,546 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $23,684 | 12,400 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $27,528 | 12,400 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,732 | 12,400 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $61,028 | 38,143 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $137,314 | 38,143 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,234,422 | 392,004 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $287,858 | 62,307 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $17,283,446 | 2,115,477 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,455,411 | 2,558,480 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $4,066,813 | 2,186,459 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,778,663 | 2,828,605 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,028,673 | 2,875,374 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $17,258,991 | 2,925,253 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,994,770 | 2,964,056 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $33,049,049 | 4,383,163 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $106,195,044 | 4,377,372 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $131,530,495 | 4,084,798 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $176,831,957 | 3,957,743 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $134,136,632 | 3,544,837 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $77,597,954 | 2,097,809 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $50,690,291 | 1,530,042 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||